C.Q. Pharmaceutical Holding Co., Ltd. (SHE:000950)
China
· Delayed Price · Currency is CNY 5.90
-0.05 (-0.84%)
Apr 29, 2026, 3:04 PM CST
SHE:000950 Revenue
C.Q. Pharmaceutical Holding had revenue of 20.43B CNY in the quarter ending March 31, 2026, a decrease of -0.87%. This brings the company's revenue in the last twelve months to 82.27B, up 0.88% year-over-year. In the year 2025, C.Q. Pharmaceutical Holding had annual revenue of 82.45B with 2.34% growth.
Revenue (ttm)
82.27B
Revenue Growth
+0.88%
P/S Ratio
0.12
Revenue / Employee
5.95M
Employees
13,820
Market Cap
10.20B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 82.45B | 1.89B | 2.34% |
| Dec 31, 2024 | 80.56B | 2.16B | 2.76% |
| Dec 31, 2023 | 78.40B | 10.57B | 15.58% |
| Jan 1, 2023 | 67.83B | 5.31B | 8.49% |
| Dec 31, 2021 | 62.52B | 17.30B | 38.26% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Qingdao Baheal Medical INC. | 7.58B |
| China National Accord Medicines Corporation | 72.95B |
| China Meheco Group | 35.36B |
| Guangxi LiuYao Group | 20.95B |
| Liaoning Cheng Da | 9.90B |
| China National Medicines Corporation | 53.31B |
| Realcan Pharmaceutical Group | 7.25B |
| Jointown Pharmaceutical Group | 164.16B |